KSC · 207940.KS
Samsung Biologics Co.,Ltd.
₩1,441,000+₩75,000 (+5.49%)
Samsung Biologics Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 27.48% below the high.
Loading market information…
KOE · 087010.KQ · KRW
Stock price, earnings
Quote as of Oct 30, 2026, 04:34 AM UTC. Cached market data; not a live quote.
One-year closing-price history · KRW. Historical prices are not a forecast.
Peptron, Inc.’s quoted price sits in the lower half of its reported 52-week range, 76.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Peptron, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Peptron, Inc. specializes in the creation of peptide-based pharmaceuticals designed to manage chronic health conditions. The company's technological expertise encompasses advanced long-acting drug delivery systems and SmartDepot, an ultrasonic spray-drying technique utilized for developing sustained-release injectable microsphere drug formulations. Their research and development pipeline features several key products: Luphere Depot, which addresses prostate cancer, endometriosis, uterine fibroids, and puberty-related issues; SR-Octreotide (PT201) for treating acromegaly; SR-Exenatide (PT302) for type 2 diabetes; and SR-Exenatide (PT320), which is aimed at Parkinson's and Alzheimer's diseases. Founded in 1997, Peptron, Inc. is headquartered in Daejeon, South Korea.
Latest available per-share figures in KRW. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:55 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₩1,441,000+₩75,000 (+5.49%)
Samsung Biologics Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 27.48% below the high.
₩191,900+₩2,600 (+1.37%)
Celltrion, Inc.’s quoted price sits in the lower half of its reported 52-week range, 19.72% below the high.
₩215,500-₩4,500 (-2.05%)
Alteogen Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.76% below the high.
₩61,100-₩2,900 (-4.53%)
LigaChem Biosciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 72.84% below the high.
₩32,700-₩1,250 (-3.68%)
Caregen Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 78.74% below the high.
₩6,730-₩30 (-0.44%)
Chabiotech Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 71.9% below the high.
₩9,470-₩330 (-3.37%)
Pharmicell Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 55.22% below the high.
₩13,470-₩610 (-4.33%)
Anterogen.Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 78.2% below the high.
